A meta-analysis study found no significant association between circulating leptin and CRC risk, while a higher level of adiponectin is significantly associated with a decreased CRC risk in men and all normal-weight people, but an increased risk among overweight people [66]. Here, ADIPOQ is linked to colorectal carcinoma.